Drug Type Small molecule drug |
Synonyms WF47JS03 |
Target |
Action inhibitors |
Mechanism RET inhibitors(Tyrosine-protein kinase receptor RET inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H38N6O2 |
InChIKeyYRBWLEAMGAGYBK-UHFFFAOYSA-N |
CAS Registry2561413-77-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | United States | 12 Feb 2020 |